Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.
The Daily Overview on MSN
7 small money tweaks that could pay off big in 2026
Household budgets are under pressure from higher prices, rising borrowing costs and a tax code that keeps shifting. The big ...
IEEE Spectrum on MSN
How to stay ahead of AI as an early-career engineer
“This is a tectonic shift,” says Hugo Malan, president of the science, engineering, technology and telecom reporting unit ...
A review of the military’s Family Advocacy Program shows that Incident Determination Committees make administrative abuse ...
NotebookLM’s audio overviews evolved into interactive podcasts and upcoming lecture mode, expanding passive learning ...
Walnut Coding (the "Company"), a leading online coding platform for young learners, unveiled its latest generation of AI-powered coding hardware at the 2025 World Internet Conference in Wuzhen, China, ...
United Natural Foods’ valuation narrative is shifting as our fair value estimate edges down to roughly $39.13 per share, mainly on slightly softer revenue growth assumptions and a marginal uptick in ...
Ginza Diamond Shiraishi Hong Kong has announced continued attention to the development and presentation of its engagement ring collections, reflecting evolving expectations around craftsmanship, ...
Late 2025 is starting to show a familiar pattern in crypto markets. Attention is no longer spread evenly. Capital is becoming selective. Large caps are slowing ...
At the start of every January, I present myself with a fresh movie challenge. I look back at the past year, note how many new releases I watched, and I begin the effort to try and top that number.
Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results